Breast Neoplasms: all 12,820 studies
Page 15 of 129. Open to participants first (2,923), then studies with results posted, then the rest; newest registration first within each.
- Efficacy and Safety of a Two-week Dosing Regimen of Vinorelbine Combined with Liposomal Doxorubicin in the Treatment of HER2-negative Advanced Breast CancerNot yet recruitingNCT06653972Phase 2
- Effectiveness of Self-Physiotherapy in the Management of LymphedemaEnrolling by invitationNCT06652295Not applicable
- Multigene Risk Score Combined With Ki-67 Dynamic Assessment in Stratified Neoadjuvant Endocrine Therapy Treatment With or Without CDK4/6 Inhibitors in HR+/HER2- Breast CancerEnrolling by invitationNCT06650748Phase 2
- Adherence to Aromatase Inhibitors ± Abemaciclib Treatment in Patients With Early-stage HER2-negative Breast CancerRecruitingNCT06650423
- Prospective Validation and Application of an Artificial Intelligence-based Model for Evaluating the Efficacy of Breast Cancer Patients After Neoadjuvant TherapyRecruitingNCT06649565
- Platform Study of ADC Rechallenge in ADC-treated Metastatic Breast CancerRecruitingNCT06649331Phase 2
- Patient Care Outreach, Navigation, Technology and Support 2.0RecruitingNCT06648278Not applicable
- Molecular Biomarkers of Response to Radiation Therapy in Breast CancerRecruitingNCT06648148
- Cellular Immune Responses in Triple-negative Breast Cancer - High Throughput Immunogenetic StudiesEnrolling by invitationNCT06646263
- PET-imaging of Two Vartumabs in Patients With Solid TumorsRecruitingNCT06645808Early Phase 1
- Evaluation of the Bexa Breast ExaminationRecruitingNCT06643767Not applicable
- AI-based Skeleton Recognition System for Rehabilitation Exercise in Breast Cancer Survivors: A Randomized Controlled TrialRecruitingNCT06642948Not applicable
- Efficacy and Safety Study of Disitamab Vedotin + RC148 vs. Albumin-Paclitaxone ± Toripalimab in HR-/HER2-low Breast CancerRecruitingNCT06642545Phase 2
- Effect of Vitamin D Supplementation on Chemotherapy Side Effects After Adjuvant Chemotherapy for Breast CancerRecruitingNCT06642441Not applicable
- Effect of Vitamin D Supplementation on the Efficacy and Adverse Effects of Neoadjuvant Therapy in Patients with Breast CancerRecruitingNCT06642428Not applicable
- The Efficacy and Safety of Different Combination Regimens of Inetetamab in First-line Treatment of HER2 Positive Metastatic Breast CancerRecruitingNCT06641544Phase 4
- Preoperative Partial Breast Reirradiation and Repeat Breast-conserving Surgery in Patients With Recurrent Breast Cancer: the REPEAT TrialRecruitingNCT06640881Phase 2
- Neoadjuvant Chemotherapy + PD-1 Inhibitor+Different Radiotherapy Fractionations for HR+/HER2- Breast CancerNot yet recruitingNCT06639672Phase 2
- Effectiveness of an N-acetylcysteine and Urea-based Cream in Prevention of Capecitabine-induced HAND-foot Syndrome in Breast Cancer PatientsRecruitingNCT06639178Not applicable
- Study in Patients With Breast Cancer Leptomeningeal MetastasisRecruitingNCT06638294
- Neoadjuvant Dupilumab, Pembrolizumab, Paclitaxel, and Carboplatin in Locally Advanced Triple Negative Breast CancerRecruitingNCT06637306Early Phase 1
- Dalpicilib-Enhanced vs. Standard Endocrine Therapy in ER+ HER2- Early Breast CancerRecruitingNCT06637150Phase 3
- All Trans Retinoic Acid Combined with Toripalimab+Chemotherapy for Locally Advanced Inoperable or Metastatic Triple Negative Breast Cancer：a Multi-center, Multi-cohort Phase II TrialRecruitingNCT06636981Phase 2
- Supplemental Screening for Women With Extremely Dense Breast Tissue: the DENSE-2 TrialRecruitingNCT06636370Not applicable
- Hypofractionated Radiotherapy Before or After Breast Surgery for Treatment of Patients With Non-Metastatic Breast CancerRecruitingNCT06635980Phase 2
- The Safety and Efficacy of Multimodal Thermal Therapy in the Treatment of Early-stage Invasive Breast CancerNot yet recruitingNCT06635096Not applicable
- MRI-Guided Ultrasound Stimulated Microbubbles Radiation Treatment for Patients with Chest-Wall and Locally Advanced Breast CancerRecruitingNCT06633601Phase 1
- Alternative Physical Activity Strategies for Breast Cancer SurvivorsRecruitingNCT06633380Not applicable
- Fast and Accurate Breast Cancer Diagnosis Using Nanopore Sequencing in Tanzania (Fast-ABCD Sequencing)RecruitingNCT06633276
- A Trial of Camrelizumab Plus Nab-paclitaxel and Levocetirizine in Metastatic or Recurrent TNBCNot yet recruitingNCT06632405Phase 2
- Evaluating the Impact of Financial Navigation on Financial Catastrophe and Distress for Cancer CareRecruitingNCT06630962Not applicable
- Contrast Enhancement Mammography vs MRI for the Surveillance of Women at High Risk of Breast Cancer: Con-trust Randomized Controlled TrialRecruitingNCT06629896Not applicable
- Open-Label Study of BBO-10203 in Subjects With Advanced Solid TumorsRecruitingNCT06625775Phase 1
- Assessment of Oncological Safety, Quality of Life, and Environmental Impact of the Green Breast Surgery ProtocolRecruitingNCT06624917Not applicable
- Early Changes in Metabolic Health in Breast Cancer Patients Initiating Endocrine TherapyNot yet recruitingNCT06623903
- A Study of Mesothelin-Targeted CAR T-Cell Therapy in People With Esophagogastric Cancer or Malignant Peritoneal MesotheliomaRecruitingNCT06623396Phase 1
- Retrospective Observational Study of the Safety and Toxicity Management of Abemaciclib in Combination with Adjuvant Hormone Therapy in Patients with RH+ ,HER2-nonoveramplified Breast Cancer, Real-life Data (MONARCHE29)RecruitingNCT06621459
- A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid TumorsRecruitingNCT06618287Phase 1/2
- Super-Hypofractionated Partial Breast IrradiationRecruitingNCT06615466Not applicable
- A PARG Inhibitor DAT-2645 Monotherapy in Patients with Advanced/Metastatic Solid Tumors Harboring BRCA1/2 Loss of Function Alterations And/or Other Defects in the DDR PathwayNot yet recruitingNCT06614751Phase 1
- An Exploratory Clinical Study of CDK4/6i Dalpiciclib Combined With AI Neoadjuvant Therapy for Stage II-III HR+/HER2- Breast CancerNot yet recruitingNCT06613373Phase 4
- Evaluation of Somatostatin Receptor Expression in PET 68Ga-DOTATOC in Patients Followed for Metastatic Breast CancerRecruitingNCT06611891Phase 3
- Neoadjuvant Chemotherapy in Combination With Toripalimab for HR+/HER2- Breast Cancer (NEOTORCH-BREAST01)RecruitingNCT06611813Phase 2
- Effect of Intravaginal Prasterone on Symptoms of Genitourinary Syndrome of Menopause (GSM) in Women in Menopause With Previous Breast CancerNot yet recruitingNCT06611514Phase 3
- BEAT-Breast: Trial of DE-iPTV in Patients With Primary Breast Cancer With Brain Metastases Who Are Not Suitable for Stereotactic Radiotherapy.RecruitingNCT06611306Not applicable
- Fasting-mimicking Diet Intervention on Side Effects of Aromatase Inhibitors Treatment in Patients With Breast CancerRecruitingNCT06610565Not applicable
- PAS 1ml Magtrace® for Sentinel Lymph Node Biopsy in Breast Cancer PatientsRecruitingNCT06610539
- A Study of GNC-077 in Patients With Locally Advanced or Metastatic Breast Cancer and Other Solid TumorsRecruitingNCT06609187Phase 1
- Effects of a Telerehabilitation Intervention in the Management of Complications After Breast Cancer SurgeryRecruitingNCT06608446Not applicable
- Reborn Lifestyle Adjustment ProgramRecruitingNCT06608043
- Personalizing the Use of Pembrolizumab for Patients Who Have a Strong Response in Early Triple Negative Breast CancerRecruitingNCT06606730Phase 3
- ENDO-BRAIN: Effects of Endocrine Adjuvant Therapy with Aromatase Inhibitors on the Cognitive Function of Breast Cancer PatientsRecruitingNCT06606535
- An Exploratory Clinical Study of Dalpiciclib an&Amp;#39;d Letrozole Combined With Anlotinib Neoadjuvant Therapy in Stage II-III Postmenopausal HR+/HER2- Early Breast CancerNot yet recruitingNCT06605690Not applicable
- To Evaluate the Efficacy and Safety of Ipsilateral Supraclavicular Lymph Node Dissection for Breast Cancer PatientsRecruitingNCT06605521
- Using CICS-1 and SPM-011 and ［18F］FBPA Commissioned by CICS and Sumitomo Heavy Industries and STELLA PHARMAEnrolling by invitationNCT06603987Phase 1/2
- HER2-positive Breast Cancer RegistryRecruitingNCT06603597
- Study on the Impact of Electroacupuncture Combined With Self-Acupressure on the Quality of Life of Patients With Early-Stage Breast Cancer Undergoing ChemotherapyRecruitingNCT06601621Not applicable
- A Single-arm, Prospective Phase Ⅱ Clinical Study of Utidelone Combined With Capecitabine in the Treatment of Active Brain Metastasis of TNBCRecruitingNCT06598046Phase 2
- Safety and Efficacy of BA1302 in Patients With Advanced Solid TumorsRecruitingNCT06596915Phase 1
- Assessing Combined SBRT in Breast Cancer Non-Responders to Neoadjuvant ChemotherapyRecruitingNCT06596018Phase 1/2
- Exploratory Research on Constructing a Computational Biological Model Based on NGS for MRD After Breast Cancer SurgeryRecruitingNCT06595966
- Breast cancEr, FITness and ExeRcise for Heart Health: The BE-FITTER StudyRecruitingNCT06595147Not applicable
- Neoadjuvant SHR-A1811 Plus Adebrelimab in HR Negative/Low & HER2 Low Breast Cancer PatientsNot yet recruitingNCT06592625Phase 2
- Asprosin in Breast CancerNot yet recruitingNCT06592560
- A Multicenter Prospective Observational Cohort Based on a Breast Cancer Medical Record Database in ChinaRecruitingNCT06591039
- Trial of 225Ac-DOTATATE (RYZ101) in Subjects With ER+, HER2-negative Unresectable or Metastatic Breast Cancer Expressing SSTRs.RecruitingNCT06590857Phase 1/2
- Psychological Well-being in Patients With Breast CancerRecruitingNCT06590727
- Ribociclib in Combination With Adjuvant Endocrine Therapy for Patients With Early High-risk HR+HER2- Breast CancerRecruitingNCT06587789
- JK-1201I in Triple Negative Breast Cancer Patients with Brain MetastasesNot yet recruitingNCT06586866Phase 2
- Breast Cancer PSMA PETRecruitingNCT06586047Early Phase 1
- Quest to Analyze One Thousand Humans MeditatingEnrolling by invitationNCT06583395
- Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple MyelomaRecruitingNCT06582017Phase 1
- Repurposing Riluzole for Cancer-Related Cognitive Impairment: A Pilot TrialRecruitingNCT06580002Phase 2
- Inetetamab Combined With Paclitaxel With/Without Pertuzumab for Previously Treated HER2-positive Advanced Breast CancerNot yet recruitingNCT06578299Phase 4
- ARX788 in HER2-positive Metastatic Breast Cancer Patients Who Were Previously Treated With T-DXdNot yet recruitingNCT06578286Phase 2
- Seroma and Hematoma Rates: MAXIGESIC IV vs. Ketorolac in Breast Cancer SurgeryNot yet recruitingNCT06575049
- Post-mastectomy Recovery: Comparing Preoperative PECS-II Blocks With Intraoperative Pectoral BlocksRecruitingNCT06574022Phase 4
- Prospective Analysis of EnVisio Spatial Intelligence for Soft Tissue Localization and Guided Surgical ExcisionRecruitingNCT06572410
- Feasibility and Acceptability of Endoscopic Mastectomy in Patients With Breast CancerRecruitingNCT06569706Not applicable
- Hypofractionated Online Adaptive Radiotherapy of Breast CancerRecruitingNCT06568705Phase 2
- A Multi-mode Thermophysical Immunotherapy Study for Breast Cancer Liver MetastasesRecruitingNCT06567353Not applicable
- The Effectiveness of E-health Intervention in Improving Mental Health Outcomes Among Breast Cancer PatientsRecruitingNCT06566937Not applicable
- Phase I Study of [177Lu]Lu-NNS309 in Patients With Pancreatic, Lung, Breast and Colorectal CancersRecruitingNCT06562192Phase 1
- To Evaluate the Effectiveness and Safety of the Single-port Robotic-assisted Breast Surgery in Breast CancerNot yet recruitingNCT06561646Not applicable
- Precision Treatment of HR+ HER2- Advanced Breast Cancer Based on SNF Molecular SubtypingNot yet recruitingNCT06561022Phase 2
- Internal Mammary Lymph Nodes Irradiation in High-risk Breast Cancer After Neoadjuvant ChemotherapyRecruitingNCT06559696Phase 3
- Ultra-Hypofractionated vs. Hypofractionated Radiation for Node-Positive Breast CancerRecruitingNCT06559540Phase 2
- 68Ga FAPI PET/CT Evaluation of Axillary Lymph Node Status After Neoadjuvant Therapy in Patients With Clinical Axillary Lymph Node Positive Breast CancerRecruitingNCT06559371
- Evaluating the Implementation of a Comprehensive Multilevel Virtual Oncology Program Among Veterans Diagnosed With Lung, Colorectal, Prostate, and Breast Cancers in the US Department of Veterans AffairsRecruitingNCT06559059Not applicable
- A Trial of HRS-6209 in Combination With Other Antitumor Therapies in Breast Cancer Patients or HRS-9813 as Monotherapy in Patients With Advanced Solid TumorsRecruitingNCT06555068Phase 1/2
- RESET-BRAIN: REhabilitation of SleEp and CogniTive Impairment in BReast Cancer Survivors Using an App-based InterventionRecruitingNCT06553235Not applicable
- Guided Digital Self-Hypnosis Solution for Managing Hot Flashes in Patients Undergoing Adjuvant Hormone TherapyRecruitingNCT06552091Not applicable
- Pemigatinib and Immune Checkpoint Inhibitor Treated FGFR1/2/3 Alteration Advanced Solid TumorNot yet recruitingNCT06551896Phase 2
- Efficacy of Trastuzumab Deruxtecan in Metastatic Breast Cancer With Different HER2 Expression PatternsRecruitingNCT06551220
- Current Status of Treatment for Chinese Patients With ESR1-mutated HR+/HER2-advanced Breast CancerRecruitingNCT06548919
- T-DXd Versus THP for Medium-risk HER2-positive Early Breast CancerNot yet recruitingNCT06548178Phase 2
- Physical and Health Outcomes With ExeRcise in Cancer SURVIVORSRecruitingNCT06547853Not applicable
- Chidamide and PD-1 Inhibitor Plus Anlotinib for HER2-low Breast Cancer That Has Spread or Cannot be Surgically RemovedNot yet recruitingNCT06547476Phase 2
- Study of Orally Administered MOMA-313 in Participants With Advanced or Metastatic Solid TumorsRecruitingNCT06545942Phase 1
- Phase Ib Study of AlpeliSib With PEmbroLizumab in Patients With mEtastatic Breast caNcer or melanomA (SELENA)RecruitingNCT06545682Phase 1